Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OrbiMed
Biotech
Electra shines with $183M fundraise for rare disease trial
The $183 million series C fundraise “reflects some encouraging signs in the market,” Electra CEO Kathy Dong told Fierce Biotech.
Gabrielle Masson
Oct 22, 2025 8:26am
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am
Sparrow flits forward with $95M for midstage diabetes asset
Sep 24, 2025 11:22am
Sitala seals $670M deal for Fosun immune disease drug
Aug 26, 2025 2:44pm
OrbiMed gets $1.86B for latest fund despite 'challenging' market
Aug 4, 2025 10:25am
Curevo clinches $110M, nabs Moncef Slaoui to lead board
Mar 17, 2025 10:44am
